The first and only hair growth supplement with published clinical studies in menopausal women with hair thinning4, its proven to improve hair growth in 3-6 months
The image below highlights the mechanisms of both GLP-1 and GIP, along with a callout to the newest treatment optiona triple incretin that also includes glucagonexpected to be approved in late 2025 to early 2026
Food and Drug Administration (FDA)-approved glucagon-like peptide-1 receptor agonists (GLP-1) anti-obesity medications, such as Zepbound and Wegovy , are flying off pharmacy shelves
Compounded products may still work for some patients, but they involve a higher level of uncertainty because equivalent clinical data does not exist
Collectively, our data provides mechanistic insight into the behaviour of Cagri as a dual CTR and AMYR agonist peptide
Packaging plays a central role in mitigating these risks